Early Cancer Detection Equipment
-
based in USA
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the next two decades, causing deaths to rise to 13M per year (worldwide). Annually, the worldwide economic impact of ...
-
Manufactured by Nucleix Ltd.based in USA
Lung cancer remains a leading cause of death from cancer globally, due to its high incidence and late-stage diagnosis. Most patients are currently diagnosed with late-stage cancer, though research has shown 5-year survival rates are up to 10 times greater when disease is detected early. Annual imaging (low-dose ...
-
Manufactured by Grail, Inc.based in USA
The earlier that cancer can be found, the higher the chance of successful treatment and survival. Yet, too often cancer goes undetected until it has progressed to an advanced ...
-
based in USA
The LuCED test is a non-intrusive sputum sample that we collect from you and then analyze using our Cell-CT machine. From this sample, LuCED is designed to detect lung cancer early by detecting the abnormal cells. ...
-
Manufactured by Amadixbased in SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of Colorectal ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
alert tool, it is valuable to physicians around the world. It is a valuable tool for early stage cancer ...
-
Manufactured by Cleveland Diagnostics, Inc.based in USA
IsoPSA Proceed to biopsy only when needed. IsoPSA is now included in NCCN® Prostate Cancer Early Detection Guidelines. IsoPSA can help reduce unnecessary prostate biopsies by up to 55%. Up to 75% of results from prostate biopsies performed in the US are negative for high-grade disease. By singling out PSA proteins that came from ...
-
by Inivata Ltdbased in USA
RaDaR™ is a personalized, multi-tumor liquid biopsy assay that can track a set of up to 48 tumor-specific variants in a patient using a liquid biopsy with exceptional sensitivity. This allows RaDaR™ to detect traces of molecular residual disease (MRD) in a patient following surgery or other treatment for cancer, enabling ...
-
Manufactured by 20/20 GeneSystems Inc.based in USA
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most cancers can be survivable when detected early enough to be surgically removed. Now, 20/20 is bringing a new ...
-
based in USA
Demonstrated extremely high sensitivity for multiple biological analytes, including: COVID-19 virus detection as sensitive as 5 TCID50, rivalling PCR sensitivity, Early liver cancer biomarker test detects target protein biomarker in as little as 5 microliters of blood. Chemical development and prototyping expected to be completed ...
-
Manufactured by Coburger Lehrmittelanstaltbased in GERMANY
Produced in co-operation with Prof. Dr. J. Sökeland, Dortmund. Made of special plastic. An urological practice model that allows rectal examinations and palpation of the testicles to be learned under true-to-life ...
-
Manufactured by VIDAR Systems Corporationbased in USA
The CAD PRO® Advantage film digitizer is specifically designed for mammography CAD. CAD systems incorporate advanced pattern recognition and image analysis, requiring a film digitizer that meets the highest standards of image quality and reliability. These advanced systems enable radiologists to improve their ability to detect early ...
-
based in USA
Smart, Accurate, & Dynamic. Our AI Learns about Your Cells Fast. In addition to three dimensional images of your cells, our technology has the ability to learn and adapt to discover which cells should raise a red flag of warning and which are completely normal in your ...
-
Manufactured by PREVENTIS GMBHbased in GERMANY
, with approximately 1.9 million new cases in 2020. In Germany alone, about 61,000 people are diagnosed with colorectal cancer every year, of which almost 25,000 die each year. The majority of these deaths could be prevented with appropriate screening, because colorectal cancer detected at an early stage is almost always curable! ...
-
Manufactured by PREVENTIS GMBHbased in GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. ...
-
Manufactured by Micrima Limitedbased in UNITED KINGDOM
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is mammography, which has limitations in women with dense breasts. MARIA® scans, with ...
-
based in USA
Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early detection of oral cancer. The clinically validated† test contributes to early and accurate† ...
-
Manufactured by Rarecells Diagnostics SASbased in FRANCE
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority of leukocytes. ISET system successfully captures CTCs that are presenting, by definition, heterogeneous phenotypic profiles. ...
-
Manufactured by Rarecells Diagnostics SASbased in FRANCE
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the primary cause of 90% of all cancer-related deaths. Circulating Tumor Cells (CTCs) ...
-
Manufactured by Grail, Inc.based in USA
GRAIL is poised to detect cancer early by combining high-intensity sequencing of unprecedented breadth and depth with the techniques of modern data science. Through what we believe to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast datasets to develop evidence supporting our ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you